SYNDAX PHARMACEUTICALS INC (SNDX) Stock Earnings Estimates
NASDAQ:SNDX • US87164F1057
20.48 USD
-0.66 (-3.12%)
At close: Feb 13, 2026
20.48 USD
0 (0%)
After Hours: 2/13/2026, 8:00:02 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 23.68M | 169.88M 617.40% | 366.43M 115.70% | 561.18M 53.15% | 754.89M 34.52% | 967.7M 28.19% | 1.168B 20.70% | 1.461B 25.09% | 1.668B 14.17% | 1.282B -23.14% | ||
| EBITDA YoY % growth | -151.77M -678.39% | -229.942M -51.51% | -339.664M -47.72% | -270.751M 20.29% | -147.78M 45.42% | -26.768M 81.89% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -151.8M -679.39% | -229.954M -51.48% | -339.672M -47.71% | -269.331M 20.71% | -128.34M 52.35% | -22.777M 82.25% | 154.81M 779.68% | 308.16M 99.06% | 463.25M 50.33% | 796.55M 71.95% | 992.33M 24.58% | 564.26M -43.14% | |
| Operating Margin | N/A | N/A | -1,434.43% | -158.54% | -35.02% | -4.06% | 20.51% | 31.84% | 39.66% | 54.52% | 59.49% | 44.01% | |
| EPS YoY % growth | -2.45 -669.77% | -2.96 -20.82% | -3.73 -26.01% | -3.19 14.45% | -1.60 49.91% | -0.18 89.00% | 1.34 864.68% | 2.44 81.79% | 3.54 44.66% | 5.41 53.11% | 6.69 23.68% | 4.78 -28.54% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 45.11% | -0.61 37.81% | -0.50 39.89% | -0.37 47.32% | -0.25 58.78% |
| Revenue Q2Q % growth | 64.629M 741.52% | 68.844M 243.50% | 83.422M 119.77% | 96.249M 109.83% | 115.64M 78.93% |
| EBITDA Q2Q % growth | -52.064M 45.76% | -51.44M 38.40% | -47.836M 31.03% | -39.693M 30.88% | N/A |
| EBIT Q2Q % growth | -51.962M 45.87% | -42.549M 49.05% | -34.146M 50.76% | -24.094M 58.04% | -10.863M 79.09% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.70 28.57% | -0.73 | 0.03 | 4.24% |
| Q2 2025 Q2Q % growth | -0.83 -3.75% | -1.04 | 0.21 | 19.92% |
| Q1 2025 Q2Q % growth | -0.98 -15.29% | -1.36 | 0.38 | 27.80% |
| Q4 2024 Q2Q % growth | -1.10 -10.00% | -0.23 | -0.87 | -370.62% |
| Q3 2024 Q2Q % growth | -0.98 -34.25% | -1.14 | 0.16 | 13.67% |
| Q2 2024 Q2Q % growth | -0.80 -25.00% | -0.93 | 0.13 | 14.20% |
| Q1 2024 Q2Q % growth | -0.85 -44.07% | -1.00 | 0.15 | 14.84% |
| Q4 2023 Q2Q % growth | -1.00 -61.29% | -1.01 | 0.01 | 1.39% |
| Q3 2023 Q2Q % growth | -0.73 -25.86% | -0.81 | 0.08 | 10.03% |
| Q2 2023 Q2Q % growth | -0.64 -3.23% | -0.75 | 0.11 | 14.31% |
| Q1 2023 Q2Q % growth | -0.59 6.35% | -0.61 | 0.02 | 2.90% |
| Q4 2022 Q2Q % growth | -0.62 -134.25% | -0.66 | 0.04 | 6.31% |
| Q3 2022 Q2Q % growth | -0.58 -45.00% | -0.65 | 0.07 | 10.45% |
| Q2 2022 Q2Q % growth | -0.62 -40.91% | -0.65 | 0.03 | 4.53% |
| Q1 2022 Q2Q % growth | -0.63 -16.67% | -0.65 | 0.02 | 2.73% |
| Q4 2021 Q2Q % growth | 1.81 511.36% | 0.28 | 1.53 | 537.56% |
| Q3 2021 Q2Q % growth | -0.40 13.04% | -0.24 | -0.16 | -69.27% |
| Q2 2021 Q2Q % growth | -0.44 -4.76% | -0.73 | 0.29 | 39.67% |
| Q1 2021 Q2Q % growth | -0.54 3.57% | -0.66 | 0.12 | 18.34% |
| Q4 2020 Q2Q % growth | -0.44 | -0.50 | 0.06 | 11.33% |
| Q3 2020 Q2Q % growth | -0.46 | -0.45 | -0.01 | -3.12% |
| Q2 2020 Q2Q % growth | -0.42 | -0.45 | 0.03 | 7.64% |
| Q1 2020 Q2Q % growth | -0.56 | -0.52 | -0.04 | -6.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 45.871M 266.97% | 48.936M | -3.065M | -6.26% |
| Q2 2025 Q2Q % growth | 37.958M 984.51% | 27.361M | 10.597M | 38.73% |
| Q1 2025 Q2Q % growth | 20.042M | 14.722M | 5.32M | 36.14% |
| Q4 2024 Q2Q % growth | 7.68M | 87.63M | -79.95M | -91.24% |
| Q3 2024 Q2Q % growth | 12.5M | 11.423M | 1.077M | 9.43% |
| Q1 2023 Q2Q % growth | 437.141K | -437.141K | -100.00% | |
| Q4 2022 Q2Q % growth | -100.00% | 382.5K | -382.5K | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | 1.403M | -1.403M | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 2.173M | -2.173M | -100.00% |
| Q4 2021 Q2Q % growth | 126.6M 31,550.00% | 59.854M | 66.746M | 111.51% |
| Q3 2021 Q2Q % growth | 12.4M 3,000.00% | 29.937M | -17.537M | -58.58% |
| Q2 2021 Q2Q % growth | 400K | 183.6K | 216.4K | 117.86% |
| Q1 2021 Q2Q % growth | 400K | 229.5K | 170.5K | 74.29% |
| Q4 2020 Q2Q % growth | 400K | 204K | 196K | 96.08% |
| Q3 2020 Q2Q % growth | 400K | 306K | 94K | 30.72% |
| Q2 2020 Q2Q % growth | 400K | 408K | -8K | -1.96% |
| Q1 2020 Q2Q % growth | 400K | 860.033K | -460.033K | -53.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.39% | 0.86% | -0.25% | -0.04% |
| Revenue | -1.15% | -1.32% | -0.38% | -2.61% |